ביאוביו 120מגמל
novartis israel ltd - brolucizumab - תמיסה להזרקה - brolucizumab 120 mg / 1 ml - brolucizumab
אבטור 10
unipharm trading ltd, israel - everolimus - טבליה - everolimus 10 mg - everolimus
אבטור 2.5
unipharm trading ltd, israel - everolimus - טבליה - everolimus 2.5 mg - everolimus
אבטור 5
unipharm trading ltd, israel - everolimus - טבליה - everolimus 5 mg - everolimus
קטופרוסול וטרינרי
hachaklait ltd - ketoprofen - תמיסה להזרקה - ketoprofen 100 mg / 1 ml
קטוסול 100 וטרינרי
comex ltd - ketoprofen - תמיסה להזרקה - ketoprofen 100 mg / 1 ml
נקסיום אבקה לתמיסה להזרקה עירוי 40 מג
taro international ltd, israel - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/dose - esomeprazole - esomeprazole - nexium iv is indicated for gastroesophageal reflux disease in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate.prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
פיקו - סלקס אורנג'
ferring pharmaceuticals ltd - citric acid anhydrous; magnesium oxide; sodium picosulfate - אבקה להכנת תמיסה - sodium picosulfate 10 mg; citric acid anhydrous 12 g; magnesium oxide 3.5 g - citric acid - citric acid - to clean the bowel prior to x-ray examination, endoscopy or surgery.
מוביפרפ
padagis israel agencies ltd, israel - ascorbic acid; macrogols; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate anhydrous - אבקה להכנת תמיסה - potassium chloride 1.015 g; sodium ascorbate 5.9 g; macrogols 100 g; sodium chloride 2.691 g; sodium sulfate anhydrous 7.5 g; ascorbic acid 4.7 g - electrolytes in combination with other drugs - electrolytes in combination with other drugs - for bowel cleansing prior to any clinical procedures requiring a clean bowel e.g. bowel endoscopy or radiology.
טרקליר 62.5 מג
j-c health care ltd - bosentan as monohydrate - טבליות מצופות פילם - bosentan as monohydrate 62.5 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease